Exane Derivatives’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History
Bought
Maintained
Sold
Other funds holding VEA
TAIM
Exane Derivatives's VEA Position: Q2 2021 in Review
Exane Derivatives sold out of Vanguard FTSE Developed Markets ETF (VEA) in Q2 2021, closing a stake of 2,375 shares — an estimated $117K sold.
Exane Derivatives first reported a position in VEA in Q1 2021 and held it in 1 quarter. The position peaked at $117K in Q1 2021. 1,557 funds tracked by Wall St. Rank hold VEA as of Q2 2021.
- Exane Derivatives reported no remaining Vanguard FTSE Developed Markets ETF position as of Q2 2021 after selling out during the quarter.
- Exane Derivatives sold 2,375 Vanguard FTSE Developed Markets ETF shares in Q2 2021, an estimated $117K.
- Exane Derivatives first reported a position in Vanguard FTSE Developed Markets ETF in Q1 2021 and held it in 1 quarter.
- Exane Derivatives's Vanguard FTSE Developed Markets ETF position peaked at $117K in Q1 2021.
- 1,557 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q2 2021.
Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.